Genome Canada announced last week that Martin Godbout is stepping down from Genome Canada after a decade as its founding president and chief executive officer.
Godbout is returning to the private sector.
In a statement, Genome Canada said Godbout "created a global presence through Genome Canada where Canadian scientists can participate in groundbreaking international research." With his team, he helped secure more than $840 million in government funding, resulting in "the leveraging of close to $1 billion in leading edge genomics and proteomics research" across the country, the non-profit organization added.
Its board has created a transition team made up of board members and management personnel who will oversea the appointment of Godbout's successor and the management and operations of Genome Canada during the interim.